SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Spekulatius who wrote (22738)12/13/2005 8:59:06 AM
From: epicure  Read Replies (1) | Respond to of 78627
 
I like PFE and had also added before the announcement, so I'm very glad to hear you like it as well. I sold my MRK position at 30.80 before the last slippage, and have decided to move that money in to other pharma stocks- and this is one. MRK's strategy wrt it's Vioxx woes is what forced me to sell. I don't like the way they are handling the whole situation.



To: Spekulatius who wrote (22738)1/27/2006 9:41:59 PM
From: Spekulatius  Respond to of 78627
 
Sold PFE and rolled the money into JNJ. JNJ after loosing the GDT battle, PFE's PE is around 12 and JNJ around 14-15 but i think JNJ growth makes up the difference. I'll probably by more JNJ in my LT portfolio as i sold 1/4 of my BMW preferred shares to lock in some LT gains and those proceeds look for a home now.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News